相关实验视频

Updated: Jan 7, 2026

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

最近的过程是开发TIM-3抗体和小分子抑制剂,用于癌症免疫治疗

Fei Huang¹, Hao Li¹, Tingting Miu¹

¹Nuclear medicine department, The Second Affiliated Hospital of Nanchang University, Nanchang 330000, PR China.

Bioorganic chemistry

|December 28, 2025

概括

本综述详细介绍了T细胞免疫球蛋白和粘素域3 (TIM-3) 抑制剂的进展,包括单克隆抗体和小分子药物. 它涵盖了临床和临床前进展,为开发新型癌症免疫疗法提供了见解.

科学领域:

免疫学免疫学免疫学
药理学药理学是指药理学的学科.
在瘤学瘤学.

背景情况:

T细胞免疫球蛋白和粘素域3 (TIM-3) 是一种免疫检查点受体.
TIM-3 负面调节免疫反应.
TIM-3是癌症治疗的一个有前途的治疗点.

研究的目的:

综合分析TIM-3抑制剂的进展情况.
讨论TIM-3单克隆抗体的临床进展.
详细介绍TIM-3小分子抑制剂的临床前发展.

主要方法:

对单克隆抗体的临床进展的审查.
对小分子抑制剂的临床前开发进行详细分析.
专注于化合物发现,结构优化和生物活动.

主要成果:

讨论了单克隆抗体的临床进展.
小分子抑制剂的临床前开发是详细的.
研究开发TIM-3抑制剂的机遇和挑战.

结论:

TIM-3 抑制剂是癌症治疗的重要研究领域.
进一步开发TIM-3抑制剂有望改善癌症治疗结果.
这一综述有助于持续开发TIM-3抑制剂.

关键词:

临床单克隆抗体临床单克隆抗体小分子抑制剂小分子抑制剂在TIM-3中,TIM-3是TIM-3.

更多相关视频

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...